Literature DB >> 18184682

Biomarker reproducibility in exhaled breath condensate collected with different condensers.

P P Rosias1, C M Robroeks, A Kester, G J den Hartog, W K Wodzig, G T Rijkers, L J Zimmermann, C P van Schayck, Q Jöbsis, E Dompeling.   

Abstract

Optimal collection and analysis of exhaled breath condensate (EBC) are prerequisites for standardisation and reproducibility of assessments. The present study aimed to assess reproducibility of EBC volume, hydrogen peroxide (H(2)O(2)), 8-isoprostane and cytokine measurements using different condensers, including a newly developed glass condenser. At four points in time, 30 healthy subjects performed sequential EBC collections randomly using the following four condensers: glass, silicone, EcoScreen (Erich Jaeger GmbH, Hoechberg, Germany) and an optimised glass condenser. In small EBC samples, H(2)O(2) was measured by spectrophotometer, 8-isoprostane by enzyme immunoassay, and cytokines by multiplexed xMAP technology (Luminex Corporation, Austin, TX, USA). The optimised glass condenser yielded significantly more EBC volume (median 2,025 microL, interquartile range 1,600-2,525). The reproducibility of EBC volume, yielded by the new glass condenser, was comparable with EcoScreen (19-20 coefficients of variation (CV)%), but was significantly better compared with silicone and glass (29-37 CV%). The new condenser was associated with significantly more detections of H(2)O(2), 8-isoprostane, interleukin-2, -4, -5 and -13, and tumour necrosis factor-alpha. Isoprostane concentrations were significantly higher using the new condenser, whereas H(2)O(2) and cytokine concentrations were not. Reproducibility of biomarkers was equally variable for all condenser types. In conclusion, significantly more exhaled breath condensate volume and biomarker detections were found using the optimised glass condenser, including higher 8-isoprostane levels. However, biomarker reproducibility in exhaled breath condensate in healthy adults was not influenced by the type of condenser.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18184682     DOI: 10.1183/09031936.00073207

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  17 in total

1.  Effects of bronchoconstriction, minute ventilation, and deep inspiration on the composition of exhaled breath condensate.

Authors:  Jason S Debley; Arpy S Ohanian; Charles F Spiekerman; Moira L Aitken; Teal S Hallstrand
Journal:  Chest       Date:  2010-04-09       Impact factor: 9.410

2.  Human breath metabolomics using an optimized non-invasive exhaled breath condensate sampler.

Authors:  Konstantin O Zamuruyev; Alexander A Aksenov; Alberto Pasamontes; Joshua F Brown; Dayna R Pettit; Soraya Foutouhi; Bart C Weimer; Michael Schivo; Nicholas J Kenyon; Jean-Pierre Delplanque; Cristina E Davis
Journal:  J Breath Res       Date:  2016-12-22       Impact factor: 3.262

3.  Early diagnosis of asthma in young children by using non-invasive biomarkers of airway inflammation and early lung function measurements: study protocol of a case-control study.

Authors:  Kim D G van de Kant; Ester M M Klaassen; Quirijn Jöbsis; Annedien J Nijhuis; Onno C P van Schayck; Edward Dompeling
Journal:  BMC Public Health       Date:  2009-06-29       Impact factor: 3.295

4.  Enhanced non-invasive respiratory sampling from bottlenose dolphins for breath metabolomics measurements.

Authors:  Konstantin O Zamuruyev; Alexander A Aksenov; Mark Baird; Alberto Pasamontes; Celeste Parry; Soraya Foutouhi; Stephanie Venn-Watson; Bart C Weimer; Jean-Pierre Delplanque; Cristina E Davis
Journal:  J Breath Res       Date:  2016-09-30       Impact factor: 3.262

5.  Effect of temperature control on the metabolite content in exhaled breath condensate.

Authors:  Konstantin O Zamuruyev; Eva Borras; Dayna R Pettit; Alexander A Aksenov; Jason D Simmons; Bart C Weimer; Michael Schivo; Nicholas J Kenyon; Jean-Pierre Delplanque; Cristina E Davis
Journal:  Anal Chim Acta       Date:  2017-12-30       Impact factor: 6.558

6.  Influence of CPAP treatment on airway and systemic inflammation in OSAS patients.

Authors:  Harun Karamanlı; Duygu Özol; K Serife Ugur; Zeki Yıldırım; Ferah Armutçu; Bulent Bozkurt; Ramazan Yigitoglu
Journal:  Sleep Breath       Date:  2012-09-04       Impact factor: 2.816

7.  Peripheral blood neutrophilia as a biomarker of ozone-induced pulmonary inflammation.

Authors:  Jenny A Bosson; Anders Blomberg; Nikolai Stenfors; Ragnberth Helleday; Frank J Kelly; Annelie F Behndig; Ian S Mudway
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

8.  Comparative analysis of selected exhaled breath biomarkers obtained with two different temperature-controlled devices.

Authors:  Frank Hoffmeyer; Monika Raulf-Heimsoth; Volker Harth; Jürgen Bünger; Thomas Brüning
Journal:  BMC Pulm Med       Date:  2009-11-30       Impact factor: 3.317

9.  Investigating the relationship between particulate matter and inflammatory biomarkers of exhaled breath condensate and blood in healthy young adults.

Authors:  Morteza Seifi; Noushin Rastkari; Mohammad Sadegh Hassanvand; Kazem Naddafi; Ramin Nabizadeh; Shahrokh Nazmara; Homa Kashani; Ahad Zare; Zahra Pourpak; Seyed Yaser Hashemi; Masud Yunesian
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

10.  Profiling the proteome of exhaled breath condensate in healthy smokers and COPD patients by LC-MS/MS.

Authors:  Marco Fumagalli; Fabio Ferrari; Maurizio Luisetti; Jan Stolk; Pieter S Hiemstra; Daniela Capuano; Simona Viglio; Laura Fregonese; Isa Cerveri; Federica Corana; Carmine Tinelli; Paolo Iadarola
Journal:  Int J Mol Sci       Date:  2012-10-29       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.